MATWIN Accelerator Programme in Oncology
Share this opportunity
Apply before 31 October 2025 to the MATWIN Innovation Programme and boost your oncology innovation
MATWIN offers an accelerator programme designed to maximise the transfer potential of oncology innovation. By relying on the ecosystem in place in France (cancer research centers, SIRICs, development structures, clusters, etc.) and Unicancer’s preclinical and clinical network, MATWIN selects and supports research projects in oncology with high development potential. The support offered helps optimize the industrial structure of the project and accelerate its development. The MATWIN programme will help you:
- Assess and increase the potential of your project in the discovery / preclinical development phase from MATWIN coaching process
- Obtain validation guidelines for your development plan (clinical strategy, indications, milestones, regulatory guidance etc.) from MATWIN International Board), experts in the field and KOLs
- Get ready for the investment phase thanks to numerous individual high added-value MATWIN coaching / mentoring sessions
- Optimize your partnership opportunities with biotechs / pharmas / investors
Eligibility
- Open to any European academic team or start-up working on oncology innovative projects
- Preclinical or early clinical stage with validated POC and defined IP
- Projects in the field of therapeutic, diagnostic, medical device, technological platform, AI tools
About MATWIN
Unique in Europe, MATWIN (Maturation & Accelerating Translation With Industry) is part of a French open-innovation approach to develop translational research in oncology and shorten the time it takes to transfer innovations to patients. Its main objective is to support innovative projects with high development potential by promoting early industrial partnerships.
⏰ Deadline: 31 October 2025
ℹ️ More Information and Registration